GlassScriptPhysician profile
Robert W Andrews
NPI 1942283890
$1,591.22
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $469 · 2020: $333 · 2021: $542 · 2022: $247.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $379.92 | 2019-2022 | |
| Exeltis, USA INC. | $191.97 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $146.78 | 2019-2022 | |
| Boston Scientific Corporation | $122.35 | 2019 | |
| Roche Diagnostics Corporation | $104.99 | 2019 | |
| Baxter Healthcare | $96.07 | 2021 | |
| Coopersurgical, INC. | $89.86 | 2020-2022 | |
| Daiichi Sankyo INC. | $81.09 | 2019-2021 | |
| Aspira Women'S Health INC | $76.12 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $58.58 | 2021-2022 | |
| Astellas Pharma US INC | $54.54 | 2019-2020 | |
| Organon LLC | $42.49 | 2021-2022 | |
| Therapeuticsmd, INC. | $38.48 | 2021-2022 | |
| Myovant Sciences INC. | $28.79 | 2021-2022 | |
| Amgen INC. | $26.59 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $25.38 | 2019-2020 | |
| Duchesnay USA Incorporated | $14.57 | 2019 | |
| Hologic Sales and Service, LLC | $12.65 | 2020 |
1 company reported research payments only; those appear in the research section below.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Andrews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.